Metin Kurtoglu

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Metin Kurtoglu
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Metin Kurtoglu:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cartesian Therapeutics, Inc. Chief Technology Officer Common Stock 62,258 $1,047,939 $16.83 06 Jan 2025 Direct
Cartesian Therapeutics, Inc. Chief Technology Officer Stock Option (Right to Buy) 79,099 $62,488 $0.7900 10 Dec 2024 Direct
Cartesian Therapeutics, Inc. Chief Technology Officer Employee Stock Option (right to buy) 47,400 02 Jan 2025 Direct

Insider Reports Filed by Metin Kurtoglu

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNAC Cartesian Therapeutics, Inc. 03 Jan 2025 2 -$81,790 4 Chief Technology Officer 07 Jan 2025, 20:05
RNAC Cartesian Therapeutics, Inc. 02 Jan 2025 2 $0 4 Chief Technology Officer 06 Jan 2025, 16:19
RNAC Cartesian Therapeutics, Inc. 09 Dec 2024 7 -$325,868 4 Chief Technology Officer 11 Dec 2024, 16:28
RNAC Cartesian Therapeutics, Inc. 19 Nov 2024 10 -$594,478 4 Chief Technology Officer 21 Nov 2024, 18:52
RNAC Cartesian Therapeutics, Inc. 14 Nov 2024 11 -$1,321,899 4 Chief Technology Officer 18 Nov 2024, 19:32
RNAC Cartesian Therapeutics, Inc. 08 Apr 2024 6 $0 4 Chief Technology Officer 10 Apr 2024, 21:30
RNAC Cartesian Therapeutics, Inc. 02 Jan 2024 2 $0 4 Chief Operating Officer 04 Jan 2024, 17:03
RNAC Cartesian Therapeutics, Inc. 13 Nov 2023 3 $0 4 Chief Operations Officer 15 Nov 2023, 16:42
RNAC Cartesian Therapeutics, Inc. 13 Nov 2023 0 $0 3 Chief Operations Officer 15 Nov 2023, 16:40